21.38
                                            전일 마감가:
              $21.27
            열려 있는:
              $21.27
            하루 거래량:
                831.24K
            Relative Volume:
              1.30
            시가총액:
                $960.66M
            수익:
              $681.75M
            순이익/손실:
              $70.47M
            주가수익비율:
              14.74
            EPS:
                1.45
            순현금흐름:
                $173.19M
            1주 성능:
              -1.66%
            1개월 성능:
              -17.04%
            6개월 성능:
                -20.52%
            1년 성능:
              +28.80%
            Pacira Biosciences Inc Stock (PCRX) Company Profile
명칭
                  
                      Pacira Biosciences Inc
                    
                전화
                  
                      650-242-8052
                    
                주소
                  
                      2000 SIERRA POINT PARKWAY, BRISBANE, NJ
                    
                PCRX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 | 
|---|---|---|---|---|---|---|
|   
                          
                                PCRX
                            
                             Pacira Biosciences Inc | 21.38 | 955.72M | 681.75M | 70.47M | 173.19M | 1.45 | 
|   
                          
                                ZTS
                            
                             Zoetis Inc | 144.09 | 63.86B | 9.39B | 2.62B | 2.22B | 5.8121 | 
|   
                          
                                TAK
                            
                             Takeda Pharmaceutical Co Adr | 13.44 | 41.80B | 29.96B | 957.25M | 4.77B | 0.2956 | 
|   
                          
                                HLN
                            
                             Haleon Plc Adr | 9.27 | 40.88B | 14.26B | 1.98B | 2.47B | 0.4327 | 
|   
                          
                                TEVA
                            
                             Teva Pharmaceutical Industries Ltd Adr | 20.48 | 22.98B | 16.70B | -157.13M | 1.19B | -0.1446 | 
|   
                          
                                UTHR
                            
                             United Therapeutics Corp | 445.43 | 19.53B | 3.08B | 1.24B | 1.07B | 25.61 | 
Pacira Biosciences Inc Stock (PCRX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 | 
|---|---|---|---|
| 2025-07-25 | 업그레이드 | Truist | Hold → Buy | 
| 2025-01-30 | 업그레이드 | Truist | Sell → Hold | 
| 2024-08-13 | 다운그레이드 | Truist | Buy → Sell | 
| 2024-08-12 | 다운그레이드 | JP Morgan | Overweight → Underweight | 
| 2024-08-12 | 다운그레이드 | Piper Sandler | Overweight → Neutral | 
| 2024-08-12 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform | 
| 2024-08-12 | 다운그레이드 | Raymond James | Outperform → Mkt Perform | 
| 2024-07-03 | 다운그레이드 | Barclays | Overweight → Equal Weight | 
| 2024-03-07 | 재개 | JP Morgan | Overweight | 
| 2023-12-20 | 개시 | Raymond James | Outperform | 
| 2023-08-03 | 업그레이드 | TD Cowen | Market Perform → Outperform | 
| 2023-01-31 | 재개 | Wedbush | Outperform | 
| 2022-10-21 | 재개 | Jefferies | Buy | 
| 2022-01-03 | 재개 | JP Morgan | Overweight | 
| 2021-07-26 | 업그레이드 | JP Morgan | Neutral → Overweight | 
| 2021-04-21 | 재개 | JP Morgan | Neutral | 
| 2021-04-09 | 개시 | Berenberg | Buy | 
| 2021-04-07 | 재개 | RBC Capital Mkts | Outperform | 
| 2021-02-11 | 다운그레이드 | Northland Capital | Outperform → Market Perform | 
| 2021-01-21 | 다운그레이드 | SVB Leerink | Outperform → Mkt Perform | 
| 2020-09-21 | 업그레이드 | Northland Capital | Market Perform → Outperform | 
| 2020-07-06 | 재확인 | Needham | Buy | 
| 2020-05-27 | 개시 | Guggenheim | Neutral | 
| 2020-04-07 | 개시 | Northland Capital | Outperform | 
| 2020-03-20 | 업그레이드 | SVB Leerink | Mkt Perform → Outperform | 
| 2020-02-24 | 재확인 | H.C. Wainwright | Buy | 
| 2020-01-24 | 개시 | SunTrust | Buy | 
| 2020-01-23 | 개시 | SunTrust | Buy | 
| 2019-11-06 | 개시 | BTIG Research | Buy | 
| 2019-06-11 | 개시 | Barclays | Overweight | 
| 2019-05-06 | 업그레이드 | Mizuho | Underperform → Neutral | 
| 2019-05-02 | 업그레이드 | Stifel | Sell → Hold | 
| 2019-02-01 | 다운그레이드 | Mizuho | Neutral → Underperform | 
| 2018-08-06 | 다운그레이드 | BofA/Merrill | Buy → Neutral | 
| 2018-04-09 | 재확인 | H.C. Wainwright | Buy | 
| 2018-03-21 | 재확인 | Mizuho | Neutral | 
| 2018-02-16 | 다운그레이드 | Needham | Buy → Hold | 
| 2018-01-19 | 개시 | Seaport Global Securities | Buy | 
| 2018-01-04 | 재확인 | Canaccord Genuity | Buy | 
| 2018-01-03 | 개시 | Leerink Partners | Mkt Perform | 
                    모두보기
                     
                  
                Pacira Biosciences Inc 주식(PCRX)의 최신 뉴스
Why Pacira BioSciences Inc. (82P) stock could outperform next yearJuly 2025 Volume & Community Consensus Picks - newser.com
Pacira BioSciences Inc. recovery potential after sell off2025 Market Overview & Community Consensus Stock Picks - newser.com
How to integrate Pacira BioSciences Inc. into portfolio analysis toolsTrade Risk Report & AI Based Buy and Sell Signals - newser.com
Building trade automation scripts for Pacira BioSciences Inc.2025 Momentum Check & Fast Moving Stock Watchlists - newser.com
Can a trend reversal in Pacira BioSciences Inc. lead to recoveryJuly 2025 Rallies & Stepwise Trade Signal Implementation - newser.com
Real time social sentiment graph for Pacira BioSciences Inc.2025 Geopolitical Influence & Reliable Breakout Stock Forecasts - newser.com
Is Pacira BioSciences Inc. stock poised for growthBuy Signal & Free Accurate Trade Setup Notifications - newser.com
Chart based analysis of Pacira BioSciences Inc. trendsJuly 2025 Update & Fast Exit Strategy with Risk Control - newser.com
Pacira to Report Third Quarter 2025 Financial Results on Thursday November 6, 2025 - markets.businessinsider.com
Pacira BioSciences Inc. stock retracement – recovery analysis2025 Growth vs Value & High Accuracy Buy Signal Tips - newser.com
Pacira Biosciences, Inc. Experiences Evaluation Revision Amidst Market Dynamics and Performance Trends - Markets Mojo
Pacira BioSciences (PCRX) Expected to Announce Quarterly Earnings on Wednesday - MarketBeat
Pacira BioSciences (Nasdaq: PCRX) sets Nov. 6 third-quarter results; call at 4:30 p.m. ET - Stock Titan
Will Pacira BioSciences Inc. stock keep outperforming rivalsMarket Sentiment Report & Technical Analysis for Trade Confirmation - newser.com
What is the fair value estimate for Pacira BioSciences Inc. (82P) stock in 2025Market Trend Review & Weekly Momentum Stock Picks - newser.com
Pacira BioSciences Presents Updated Three-Year Data Demonstrating Sustained Efficacy and Safety of PCRX-201 Gene Therapy for Patients with Moderate-to-Severe Osteoarthritis of the Knee - markets.businessinsider.com
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Pacira BioSciences, Inc. (PCRX) and Encourages Shareholders to Learn More About the Investigation - ACCESS Newswire
Pacira BioSciences, Inc. Presents Updated Three-Year Data Demonstrating Sustained Efficacy and Safety of PCRX-201 Gene Therapy for Patients with Moderate-To-Severe Osteoarthritis of the Knee - MarketScreener
Pacira BioSciences (PCRX) Reports Promising Three-Year Findings for PCRX-201 - GuruFocus
Is Pacira BioSciences Inc. stock a buy on dipsForecast Cut & Smart Investment Allocation Insights - Fundação Cultural do Pará
Pacira Biosciences Increceives Paragraph IV notice from Qilu Pharmaceutical - MarketScreener
Pacira BioSciences receives patent challenge for EXPAREL from Chinese firm - Investing.com
Pacira BioSciences Notified of Abbreviated New Drug Application Filing from Qilu Pharmaceutical (Hainan) Co., Ltd. for EXPAREL® - The Manila Times
Pacira BioSciences Receives PIV Notice from Qilu Pharmaceutical Regarding Generic EXPAREL Patent Claims - Quiver Quantitative
Pacira BioSciences (NASDAQ: PCRX) notes PIV ANDA for EXPAREL; 45 days to file suit - Stock Titan
How Pacira BioSciences Inc. stock trades before earnings2025 Risk Factors & Low Drawdown Momentum Ideas - newser.com
Pacira Biosciences Inc (PCRX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
                자본화:
                 
                  | 
                볼륨(24시간):
                 
            
         
                     
                             Stockscreener 앱 받기
                    Stockscreener 앱 받기